entertainment -WSS

entertainment

author：explore 2025-08-19 18:02:42 - browse：1

Two hands hold a box of four Wegovy pens — first opinion coverage from STAT — Cydni Elledge/The New York Times

The news about anti-obesity drugs keeps getting better. In November, data presented at the American Heart Association meeting added cardiovascular benefit to value in combating obesity and diabetes. This comes on the heels of news that Novo Nordisk halted a clinical trial to test Wegovy’s impact on renal function early because the results they were seeing were so strong.

Yet beneath the hype lies a real fear. Unless we reverse the rising tide of metabolic syndrome, Medicare will be crushed, with tens of millions of Americans having shorter, harder lives. The new drugs offer the first real chance to deploy at scale treatments to halt a seemingly unstoppable trend.

That will be costly. But so is the status quo. Medicare spending on people with advanced metabolic disease is sobering. Beneficiaries with two or more of the costliest conditions — diabetes, heart failure, or chronic kidney disease — comprise just 10% of beneficiaries, according to the NIH’s Renal Data System 2022 Annual Data Report. Yet they account for 25% of total costs. Those with all three conditions are 2% of beneficiaries but almost 7% of costs. And remember, the current cohort of Medicare beneficiaries turned 65 when obesity and diabetes rates were lower, meaning unless we do something dramatic, and fast, these percentages will balloon.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Bryan Kohberger seeks indictment dismissal in Idaho college killings case

explore

leisure time

WSS

Methadone treatment changes are coming. Do they go far enough?

Plastic surgeons increase patient psychiatric screenings

Marc Tessier

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

Timeline: Special counsel's probe into Trump's handling of classified documents

As the dark side of IVF slowly comes into focus, even more transparency is needed

focus

entertainment

focus

Medicare proposal to cover medical devices draws a mixed reaction

The Jan. 6 committee previously recommended Trump be criminally charged. Here's why

Wildfire smoke exposes gaps in outdoor worker protections

Positive childhood experiences can help future health

Wildfire smoke exposes gaps in outdoor worker protections

Trader Joe's recalls 10K cases of broccoli cheddar soup over potential foreign material

Wildfire smoke exposes gaps in outdoor worker protections

CDC: Cases of alpha

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Plastic surgeons increase patient psychiatric screenings

focus

Future doctors should be trained to promote social change

Interest rates are at a 22

Plastic surgeons increase patient psychiatric screenings

Leading voice in opioid treatment defends methadone clinic system

Health AI adoption puts security, privacy startups on investors' radar

Gene editing the human germline: What are the risks?

explore

knowledge

leisure time

focus